Hormonal effects of toremifene in breast cancer patients

I. Számel, B. Vincze, I. Hindy, S. Kerpel-Fronius, S. Eckhardt, J. Mäenpää, M. Grönroos, L. Kangas, H. Sundquist, A. Hajba

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The effect of toremifene treatment on the serum levels of sex steroids (estradiol, progesterone, testosterone), FSH, LH, prolactin, TSH, T3, T4 and SHBG was investigated. Basal prolactin level and the "prolactin reserve capacity" of the hypophysis was also studied by the TRH functional test. Steroid hormone receptors were detected in the patients where a tumor biopsy could be obtained. In a randomized trial patients were treated by 60 and 300 mg of toremifene per os, daily. Hormone levels were assayed prior to treatment and at the 2nd, 6th, 8th and 12th week of toremifene therapy. The hormonal effects of toremifene were the most marked at the 2nd and at the 8th week. Estradiol decreased continuously, SHBG increased slightly and the high initial value of basal prolactin level decreased. The TRH induced prolactin release was suppressed by toremifene after an 8-week period. No clinical response-related tendency was found.

Original languageEnglish
Pages (from-to)243-247
Number of pages5
JournalJournal of Steroid Biochemistry
Volume36
Issue number3
DOIs
Publication statusPublished - Jun 22 1990

Fingerprint

Toremifene
Prolactin
Breast Neoplasms
Estradiol
Steroid hormones
Hormones
Biopsy
Steroid Receptors
Pituitary Gland
Progesterone
Testosterone
Tumors
Therapeutics
Steroids
Serum
Neoplasms

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Számel, I., Vincze, B., Hindy, I., Kerpel-Fronius, S., Eckhardt, S., Mäenpää, J., ... Hajba, A. (1990). Hormonal effects of toremifene in breast cancer patients. Journal of Steroid Biochemistry, 36(3), 243-247. https://doi.org/10.1016/0022-4731(90)90018-N

Hormonal effects of toremifene in breast cancer patients. / Számel, I.; Vincze, B.; Hindy, I.; Kerpel-Fronius, S.; Eckhardt, S.; Mäenpää, J.; Grönroos, M.; Kangas, L.; Sundquist, H.; Hajba, A.

In: Journal of Steroid Biochemistry, Vol. 36, No. 3, 22.06.1990, p. 243-247.

Research output: Contribution to journalArticle

Számel, I, Vincze, B, Hindy, I, Kerpel-Fronius, S, Eckhardt, S, Mäenpää, J, Grönroos, M, Kangas, L, Sundquist, H & Hajba, A 1990, 'Hormonal effects of toremifene in breast cancer patients', Journal of Steroid Biochemistry, vol. 36, no. 3, pp. 243-247. https://doi.org/10.1016/0022-4731(90)90018-N
Számel I, Vincze B, Hindy I, Kerpel-Fronius S, Eckhardt S, Mäenpää J et al. Hormonal effects of toremifene in breast cancer patients. Journal of Steroid Biochemistry. 1990 Jun 22;36(3):243-247. https://doi.org/10.1016/0022-4731(90)90018-N
Számel, I. ; Vincze, B. ; Hindy, I. ; Kerpel-Fronius, S. ; Eckhardt, S. ; Mäenpää, J. ; Grönroos, M. ; Kangas, L. ; Sundquist, H. ; Hajba, A. / Hormonal effects of toremifene in breast cancer patients. In: Journal of Steroid Biochemistry. 1990 ; Vol. 36, No. 3. pp. 243-247.
@article{11891fbd4e5347d8b8ce3494adce246c,
title = "Hormonal effects of toremifene in breast cancer patients",
abstract = "The effect of toremifene treatment on the serum levels of sex steroids (estradiol, progesterone, testosterone), FSH, LH, prolactin, TSH, T3, T4 and SHBG was investigated. Basal prolactin level and the {"}prolactin reserve capacity{"} of the hypophysis was also studied by the TRH functional test. Steroid hormone receptors were detected in the patients where a tumor biopsy could be obtained. In a randomized trial patients were treated by 60 and 300 mg of toremifene per os, daily. Hormone levels were assayed prior to treatment and at the 2nd, 6th, 8th and 12th week of toremifene therapy. The hormonal effects of toremifene were the most marked at the 2nd and at the 8th week. Estradiol decreased continuously, SHBG increased slightly and the high initial value of basal prolactin level decreased. The TRH induced prolactin release was suppressed by toremifene after an 8-week period. No clinical response-related tendency was found.",
author = "I. Sz{\'a}mel and B. Vincze and I. Hindy and S. Kerpel-Fronius and S. Eckhardt and J. M{\"a}enp{\"a}{\"a} and M. Gr{\"o}nroos and L. Kangas and H. Sundquist and A. Hajba",
year = "1990",
month = "6",
day = "22",
doi = "10.1016/0022-4731(90)90018-N",
language = "English",
volume = "36",
pages = "243--247",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Hormonal effects of toremifene in breast cancer patients

AU - Számel, I.

AU - Vincze, B.

AU - Hindy, I.

AU - Kerpel-Fronius, S.

AU - Eckhardt, S.

AU - Mäenpää, J.

AU - Grönroos, M.

AU - Kangas, L.

AU - Sundquist, H.

AU - Hajba, A.

PY - 1990/6/22

Y1 - 1990/6/22

N2 - The effect of toremifene treatment on the serum levels of sex steroids (estradiol, progesterone, testosterone), FSH, LH, prolactin, TSH, T3, T4 and SHBG was investigated. Basal prolactin level and the "prolactin reserve capacity" of the hypophysis was also studied by the TRH functional test. Steroid hormone receptors were detected in the patients where a tumor biopsy could be obtained. In a randomized trial patients were treated by 60 and 300 mg of toremifene per os, daily. Hormone levels were assayed prior to treatment and at the 2nd, 6th, 8th and 12th week of toremifene therapy. The hormonal effects of toremifene were the most marked at the 2nd and at the 8th week. Estradiol decreased continuously, SHBG increased slightly and the high initial value of basal prolactin level decreased. The TRH induced prolactin release was suppressed by toremifene after an 8-week period. No clinical response-related tendency was found.

AB - The effect of toremifene treatment on the serum levels of sex steroids (estradiol, progesterone, testosterone), FSH, LH, prolactin, TSH, T3, T4 and SHBG was investigated. Basal prolactin level and the "prolactin reserve capacity" of the hypophysis was also studied by the TRH functional test. Steroid hormone receptors were detected in the patients where a tumor biopsy could be obtained. In a randomized trial patients were treated by 60 and 300 mg of toremifene per os, daily. Hormone levels were assayed prior to treatment and at the 2nd, 6th, 8th and 12th week of toremifene therapy. The hormonal effects of toremifene were the most marked at the 2nd and at the 8th week. Estradiol decreased continuously, SHBG increased slightly and the high initial value of basal prolactin level decreased. The TRH induced prolactin release was suppressed by toremifene after an 8-week period. No clinical response-related tendency was found.

UR - http://www.scopus.com/inward/record.url?scp=0025365869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025365869&partnerID=8YFLogxK

U2 - 10.1016/0022-4731(90)90018-N

DO - 10.1016/0022-4731(90)90018-N

M3 - Article

C2 - 2142246

AN - SCOPUS:0025365869

VL - 36

SP - 243

EP - 247

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 3

ER -